Patents by Inventor Beverly E. Barton

Beverly E. Barton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Glutamate-enhanced cell-penetrating peptides and methods of using same
    Patent number: 8389481
    Abstract: Disclosed herein are novel glutamate-enhanced cell-penetrating peptides (CPPs) for use as delivery vehicles to mediate intracellular uptake of therapeutic payloads and methods of using the same.
    Type: Grant
    Filed: November 12, 2009
    Date of Patent: March 5, 2013
    Assignee: University of Medicine and Dentistry of New Jersey
    Inventors: Beverly E. Barton, H. Dan Lewis, Robert J. Donnelly, Ali Husain, Dimitrios Barlos, Sheraz Riaz
  • Glutamate-Enhanced Cell-Penetrating Peptides and Methods of Using Same
    Publication number: 20100137187
    Abstract: Disclosed herein are novel glutamate-enhanced cell-penetrating peptides (CPPs) for use as delivery vehicles to mediate intracellular uptake of therapeutic payloads and methods of using the same.
    Type: Application
    Filed: November 12, 2009
    Publication date: June 3, 2010
    Inventors: Beverly E. Barton, H. Dan Lewis, Robert J. Donnelly, Ali Husain, Dimitrios Barlos, Sheraz Riaz
  • Prevention of lens-related tissue growth in the eye
    Patent number: 4966577
    Abstract: Disclosed is a composition for preventing secondary cataract formation in the eye following removal of the lens, comprising an antibody specific to particular lens cells related to secondary cataract formation, which antibody is conjugated to an antiproliferative agent. The particularly preferred antiproliferative agents require activation after binding of the antibody to the target cells, and activation may be accomplished by addition of a second composition or by exposure of the eye to electromagnetic energy.Also disclosed is a method of using the composition by administering it directly to the site from which the lens was removed to kill or prevent proliferation of lens cells.
    Type: Grant
    Filed: March 16, 1988
    Date of Patent: October 30, 1990
    Assignee: Allergan, Inc.
    Inventors: Craig E. Crosson, Beverly E. Barton, William H. Garner, Arlene E. Gwon